Drug adverse event reports (FAERS)

Injury

Drugs: SPRAVATO

SeriousOther seriousReport 26940059
Safetyreportversion
1
Safetyreportid
26940059
Primarysourcecountry
US
Occurcountry
US
Transmissiondateformat
102
Transmissiondate
20260709
Reporttype
2
Serious
1
Seriousnessdeath
2
Seriousnesslifethreatening
2
Seriousnesshospitalization
2
Seriousnessdisabling
2
Seriousnesscongenitalanomali
2
Seriousnessother
1
Receivedateformat
102
Receivedate
20260630
Receiptdateformat
102
Receiptdate
20260630
Fulfillexpeditecriteria
1
Companynumb
US-JNJFOC-20260636700
Primarysource
Reportercountry
US
Qualification
3
Sender
Sendertype
6
Senderorganization
JOHNSON AND JOHNSON
Receiver
Receivertype
6
Receiverorganization
FDA
Patient
Patientsex
2
Reaction
  1. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Injury
    Reactionoutcome
    6
Drug
  1. Drugcharacterization
    1
    Medicinalproduct
    SPRAVATO
    Drugauthorizationnumb
    211243
    Drugseparatedosagenumb
    1
    Drugdosageform
    Nasal spray
    Drugadministrationroute
    045
    Drugindication
    Depression
    Actiondrug
    5
    Drugrecurreadministration
    3
    Drugadditional
    3
    Activesubstance
    Activesubstancename
    ESKETAMINE
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

How to read this: Each report says someone told FDA an event happened while a product was used. A report does not show the product caused it, and counts rise and fall with how many people report. Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.